跳到主要內容

Gibson Christopher 的 Form 4/A 修正申報

修正

Recursion Pharmaceuticals, Inc.(RXRX),2023/4/28 申報

申報編號
0001209191-23-026045
申報時間
2023/4/28
交易日
2022/1/5-12/14
申報延遲
478 天
10b5-1 計畫
沒有勾選
原始申報日
2023/1/6

這份申報列了 22 筆非衍生性交易、11 筆衍生性交易。公開市場賣出合計 $13.7 萬。交易後 478 天申報。

這份修正申報取代了 0001209191-23-002460(2023/1/6 申報)。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Gibson ChristopherCIK 0001856369董事、高階主管(執行長)

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2022/4/25Class A Common StockC轉換取得+12,000$0.00$0594,805直接
2022/4/25Class A Common StockG贈與處分−12,000$0.00$0582,805直接
2022/5/12Class A Common StockC轉換取得+12,000$0.00$0594,805直接
2022/5/12Class A Common StockG贈與處分−12,000$0.00$0582,805直接
2022/5/19Class A Common StockC轉換取得+12,000$0.00$0594,805直接
2022/5/19Class A Common StockG贈與處分−12,000$0.00$0582,805直接
2022/6/21Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/6/21Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/7/19Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/7/19Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/8/17Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/8/17Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/9/19Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/9/19Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/10/19Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/10/19Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/11/16Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/11/16Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/12/14Class A Common StockC轉換取得+3,000$0.00$0585,805直接
2022/12/14Class A Common StockG贈與處分−3,000$0.00$0582,805直接
2022/1/5Class A Common StockC轉換取得+18,500$0.00$0601,305直接
2022/1/5Class A Common StockS賣出處分−18,500$7.39F5−$136,715582,805直接

衍生性證券(表 II)

選擇權、認股權證、限制型股票單位等。股數是標的股票的股數;單價與金額是衍生證券本身的價格,交易後持有是衍生證券的單位數。

衍生性證券的交易
交易日證券交易標的股數單價金額交易後持有持有方式旗標
2022/4/25Class A Common StockC轉換處分−12,000$0.00$06,665,334直接
2022/5/12Class A Common StockC轉換處分−12,000$0.00$06,653,334直接
2022/5/19Class A Common StockC轉換處分−12,000$0.00$06,641,334直接
2022/6/21Class A Common StockC轉換處分−3,000$0.00$06,638,334直接
2022/7/19Class A Common StockC轉換處分−3,000$0.00$06,635,334直接
2022/8/17Class A Common StockC轉換處分−3,000$0.00$06,632,334直接
2022/9/19Class A Common StockC轉換處分−3,000$0.00$06,629,334直接
2022/10/19Class A Common StockC轉換處分−3,000$0.00$06,626,334直接
2022/11/16Class A Common StockC轉換處分−3,000$0.00$06,623,334直接
2022/12/14Class A Common StockC轉換處分−3,000$0.00$06,620,334直接
2022/1/5Class A Common StockC轉換處分−18,500$0.00$06,601,834直接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F1

Transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2

The sole purpose of this amended Form 4 is to correctly reflect that the shares gifted between April 25, 2022 and December 14, 2022 were first converted from the Reporting Person's holdings of Class B common stock.

F3

Represents the automatic conversion of Class B Common Stock into Class A Common Stock in connection with a bona-fide gift of shares by the Reporting Person.

F4

Represents the conversion of Class B Common Stock into Class A Common Stock.

F5

This transaction was executed in multiple trades at prices ranging from $7.29 to $7.71. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

表 I 有 1 筆交易的價格引用這則附註。

F6

Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

看 SEC EDGAR 上的完整原文 (在新分頁開啟)